Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7462.074 | 0.6479 | -0.0153 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7462.074 | 0.2783 | -0.7520 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7462.074 | 0.2783 | -0.7520 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7462.074 | 0.2001 | -0.8553 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7462.074 | 0.2001 | -0.8553 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7462.074 | 0.1261 | -0.9319 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7462.074 | 0.1261 | -0.9319 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7462.074 | 0.0726 | -0.9723 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 33.3 | uM | 7462.074 | 0.0726 | -0.9723 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 167 | uM | 7462.074 | 0.1073 | -0.9477 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 167 | uM | 7462.074 | 0.1073 | -0.9477 | 0.6126 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7463.074 | 1.0041 | 1.0178 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.000427 | uM | 7463.074 | 1.0041 | 1.0178 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7463.074 | 0.9968 | 0.9860 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.00213 | uM | 7463.074 | 0.9968 | 0.9860 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7463.074 | 0.9526 | 0.7985 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.0107 | uM | 7463.074 | 0.9526 | 0.7985 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7463.074 | 0.6213 | -0.2936 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.0533 | uM | 7463.074 | 0.6213 | -0.2936 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7463.074 | 0.3484 | -0.8005 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 0.267 | uM | 7463.074 | 0.3484 | -0.8005 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7463.074 | 0.4162 | -0.7057 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 1.33 | uM | 7463.074 | 0.4162 | -0.7057 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7463.074 | 0.3167 | -0.8381 | 0.4574 | |
| HCC2185 | TNBC | Luminal | Bortezomib | Proteasome | Proteasome | 6.67 | uM | 7463.074 | 0.3167 | -0.8381 | 0.4574 |